Back
For best output, select "Paper Size" as "A4" and "Margin" as "0" or "None".
To save or print to PDF, please select Print Destination > Save as PDF, enable Background Graphics under "More Settings", then click "Save".
During the congress, E-Posters will be accessible to all participants on the congress website 24/7, as well as in the E-poster stations in the congress center.
Preparing your E-Poster
Please review the E-Poster format requirements carefully when preparing your E-Poster. Should your E-Poster not meet the mentioned requirements, it may not be displayed as described above.
E-Poster Submission Deadline
Please prepare and upload your E-Poster no later than March 14, 2026 11.59PM CET. After this date, you will no longer be able to prepare and upload your E-poster and it will not be displayed and accessible on the congress website.
Please follow the instructions below to input your abstract title.
Abstract titles should be brief and reflect the content of the abstract.
A 68-year-old man with chronic renal failure due to diabetic nephropathy underwent peritoneal dialysis (PD) catheter insertion in January, Year X, and initiated PD on March 5. Within several days, he mastered the PD technique independently, was discharged, returned to work, and initially maintained a good quality of life.
However, in early April, he developed listlessness, cognitive decline, and increasing dependence, spending most of the day bedridden. On April 18, as his level of consciousness deteriorated and he was unable to eat, he was brought for an emergency evaluation by his family. Computed tomography of the head revealed a tumorous lesion with extensive severe edema in the left frontal lobe. He was admitted the same day, continued PD with full nursing assistance, and subsequently underwent complete resection of the brain tumor on May 2.
Histopathology confirmed glioblastoma (IDH-wild type). From May 26 to July 6, the patient received radiotherapy (60 Gy/30 fractions) combined with temozolomide (140 mg/body; standard dose). No significant treatment-related adverse events occurred. His impaired consciousness gradually improved, and he regained the ability to eat independently. Although motor aphasia and right hemiplegia persisted, he was able to use a wheelchair with assistance. He was transferred to a local hospital for rehabilitation, where maintenance therapy with temozolomide was continued. During this time, PD was performed with the assistance of nurses and caregivers, allowing him to live peacefully until April, Year X+2.
The 5-year survival rate of glioblastoma patients diagnosed in their 60s is 4.7%, representing the poorest prognosis among brain tumors and curative treatment is extremely difficult. According to classification by recursive partitioning analysis (RPA), this case corresponds to the most severe Class V, associated with a median survival of 7.5 months. However, the patient survived for 24 months after onset, suggesting a degree of therapeutic efficacy. While several reports describe glioblastoma treatment in hemodialysis patients, only one prior case report has documented glioblastoma treatment in a PD patient. Therefore, this case represents a valuable contribution, and we report its clinical course.
